Post-COVID-19 Syndrome Clinical Trial
Official title:
Post-COVID-19 Chronic Fatigue Syndrome
| Verified date | September 2023 |
| Source | ClinAmygate |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Fatigue is recognized as one of the most commonly presented long-term complaints in individuals previously infected with SARS-CoV-2.
| Status | Recruiting |
| Enrollment | 480 |
| Est. completion date | December 8, 2023 |
| Est. primary completion date | October 8, 2023 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Age . 18 - Male or female - Post-Covid-19 Fatigue Exclusion Criteria: - refusal |
| Country | Name | City | State |
|---|---|---|---|
| Egypt | Asalam | Maadi | Cairo |
| Lead Sponsor | Collaborator |
|---|---|
| ClinAmygate | As-Salam Center, Maadi, Cairo, Egypt |
Egypt,
Jackson C. The Chalder Fatigue Scale (CFQ 11). Occup Med (Lond). 2015 Jan;65(1):86. doi: 10.1093/occmed/kqu168. No abstract available. — View Citation
Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Hanitsch LG, Zoller T, Steinbeis F, Haffke M, Rudolf G, Heidecker B, Bobbert T, Spranger J, Volk HD, Skurk C, Konietschke F, Paul F, Behrends U, Bellmann-Strobl J, Scheibenbogen C. A prospective observational s — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Fatigue scale | chalder fatigue scale | one month | |
| Primary | Fatigue scale | chalder fatigue scale | two month |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06073002 -
Effects of a Home-Based Exercise Intervention in Subjects With Long COVID
|
N/A | |
| Completed |
NCT05047952 -
Vortioxetine for Post-COVID-19 Condition
|
Phase 2 | |
| Completed |
NCT05812209 -
Stellate Ganglion Block to Treat Long COVID 19 Case Series
|
||
| Recruiting |
NCT06091384 -
Inspiratory Muscle Strength Training in Post-Covid Syndrome
|
N/A | |
| Not yet recruiting |
NCT06267300 -
Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial
|
Phase 3 | |
| Recruiting |
NCT05986422 -
Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS)
|
Phase 2 | |
| Not yet recruiting |
NCT05534997 -
Rehabilitation Therapy for Post COVID 19 Chronic Fatigue Syndrome
|
N/A | |
| Recruiting |
NCT05638633 -
Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome
|
Phase 3 | |
| Active, not recruiting |
NCT05630040 -
VNS for Long-COVID-19
|
N/A | |
| Recruiting |
NCT05841498 -
Immunoadsorption Study Mainz in Adults With Post-COVID Syndrome
|
N/A | |
| Enrolling by invitation |
NCT05981872 -
EFFECT OF COGNITIVE BEHAVIORAL THERAPY ON DEPRESSION AND QUALITY OF LIFE IN PATIENTS WITH POST COVID-19
|
N/A | |
| Active, not recruiting |
NCT05543408 -
Long COVID-19 Syndrome in Primary Care: A Novel Protocol of Exercise Intervention "CON-VIDA Clinical Trial"
|
N/A | |
| Recruiting |
NCT05817032 -
Effect of Telerehabilitation Practice in Long COVID-19 Patients
|
N/A | |
| Recruiting |
NCT05823896 -
imPROving Quality of LIFe In the Long COVID Patient
|
Phase 2 | |
| Completed |
NCT05764070 -
Impact of Vagus Nerve Stimulation on Post-Aerobic Activity Recovery in Post SARS-CoV-2 Patients
|
N/A | |
| Completed |
NCT05765591 -
Balneotherapy for Patients With Post-acute Coronavirus Disease (COVID) Syndrome
|
N/A | |
| Recruiting |
NCT05918965 -
Vagus Stimulation in Female Long COVID Patients.
|
N/A | |
| Not yet recruiting |
NCT06231238 -
Balance Acceptance and Commitment Therapy for Long COVID
|
Phase 2 | |
| Completed |
NCT06282627 -
The COVID HOME Study: Prospective Cohort Study of Non-hospitalised COVID-19 Patients
|
||
| Completed |
NCT05648734 -
Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis
|